Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Robinson

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 27, 2021
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with LenvatinibMatthew H Taylor, Shunji Takahashi, Jaume Capdevila, et al.
Thyroid : Official Journal of the American Thyroid Association|May 27, 2022
A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer OutcomesAyanthi Wijewardene, Anthony J Gill, Matti Gild, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Bone|September 8, 2019
International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDoppsSophie Liabeuf, Keith McCullough, Eric W Young, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2013
Estimating prevalence of CKD stages 3-5 using health system dataVahakn B Shahinian, Elizabeth Hedgeman, Brenda W Gillespie, et al.
Kidney Medicine|August 1, 2020
Remote Management for Peritoneal Dialysis: A Qualitative Study of Patient, Care Partner, and Clinician Perceptions and Priorities in the United States and the United KingdomLalita Subramanian, Rosalind Kirk, Tony Cuttitta, et al.
Kidney International Reports|May 16, 2022
Mortality Trends After Transfer From Peritoneal Dialysis to HemodialysisAnnie-Claire Nadeau-Fredette, Nidhi Sukul, Mark Lambie, et al.
Kidney International|July 1, 2021
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysisRajnish Mehrotra, Ian B Stanaway, Gail P Jarvik, et al.
Annals of Surgical Oncology|July 19, 2021
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 27, 2021
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with LenvatinibMatthew H Taylor, Shunji Takahashi, Jaume Capdevila, et al.
Thyroid : Official Journal of the American Thyroid Association|May 27, 2022
A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer OutcomesAyanthi Wijewardene, Anthony J Gill, Matti Gild, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Bone|September 8, 2019
International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDoppsSophie Liabeuf, Keith McCullough, Eric W Young, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2013
Estimating prevalence of CKD stages 3-5 using health system dataVahakn B Shahinian, Elizabeth Hedgeman, Brenda W Gillespie, et al.
Kidney Medicine|August 1, 2020
Remote Management for Peritoneal Dialysis: A Qualitative Study of Patient, Care Partner, and Clinician Perceptions and Priorities in the United States and the United KingdomLalita Subramanian, Rosalind Kirk, Tony Cuttitta, et al.
Kidney International Reports|May 16, 2022
Mortality Trends After Transfer From Peritoneal Dialysis to HemodialysisAnnie-Claire Nadeau-Fredette, Nidhi Sukul, Mark Lambie, et al.
Kidney International|July 1, 2021
A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysisRajnish Mehrotra, Ian B Stanaway, Gail P Jarvik, et al.
Annals of Surgical Oncology|July 19, 2021
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Pageof 17